Vaccine | Financial Buzz

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Moderna Announces Development of Single-Dose Booster for Covid and Flu

Rebecca Urena09/09/202109/09/2021

2021

Modena (NASDAQ: MRNA) shares rose over 5% on Thursday after announcing it is developing a single-shot vaccine booster shot for both Covid-19 and the flu. According to a press...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Moderna, Inc. (NASDAQ: MRNA) Provisional Registration for Covid-19 Vaccine

financial buzz08/09/2021

1708

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Moderna, Inc. Granted Provisional Registration for its Covid-19 Vaccine by the Therapeutic Goods Administration” Moderna, Inc. (NASDAQ: MRNA)...

Biotechnology Healthcare Investing News Market News Medical Use Pharmaceutical Products The Market Buzz

Johnson & Johnson Reports Better-than-Expected Earnings

Rebecca Urena07/21/202107/21/2021

2837

Johnson & Johnson (NYSE: JNJ) released its second-quarter financial results on Wednesday, with earnings and revenue surpassing Wall Street expectations. The company now anticipates to sell USD2.5 Billion of...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

FDA to Place Warning on J&J Covid-19 Vaccine Regarding Rare Disorder

Rebecca Urena07/13/202107/13/2021

4113

The Food and Drug Administration (FDA) revealed it would be placing a warning on the Johnson & Johnson Covid-19 (NYSE: JNJ) vaccine, as the shot has been associated with...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

FDA adds Heart Inflammation Warning on Pfizer & Moderna Covid Vaccines

Rebecca Urena06/28/202106/28/2021

3803

On Friday, the U.S. Food and Drug Administration added a warning to Moderna and Pfizer-BioNTech Covid-19 vaccines regarding a rare risk of heart inflammation. Pfizer and Moderna’s fact sheets...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products Technology The Market Buzz Your Environment

Moderna Applies for Full FDA Approval of its COVID-19 Vaccine

Rebecca Urena06/01/202106/01/2021

3011

Moderna (NASDAQ: MRNA), an American pharmaceutical, announced it has applied for full approval from the Food and Drug Administration for its Covid-19 vaccine. It is the second U.S. drugmaker...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

WHO Grants Emergency Use Authorization to Sinopharm Covid-19 Vaccine

Rebecca Urena05/10/2021

2602

The World Health Organization has granted emergency use authorization for a Covid-19 vaccine made by, China’s state-owned drugmakers, Sinopharm (OTCMKTS: SHTDY). The vaccine is one of the two coronavirus...

Healthcare Investing News Market News Medical Use Pharmaceutical Products Retail The Market Buzz

CVS Health Tops Estimates & Boosts 2021 Guidance

Rebecca Urena05/04/2021

2915

CVS Health (NYSE: CVS) reported positive first quarter earnings Tuesday and increased its full-year outlook amid the influx of Covid-19 vaccines, tests and prescriptions. The pharmaceutical chain has been...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: INOVIO (NASDAQ: INO) Plans Phase 3 Trial for INO-4800

financial buzz04/23/2021

2054

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “INOVIO Announced that the U.S. Govt has Stopped Funding for its Late-Stage Covid-19 Vaccine Study” INOVIO (NASDAQ: INO)...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

FDA Cites Drawbacks at Emergent BioSolutions Vaccine Plant

Rebecca Urena04/21/202104/21/2021

2818

On Wednesday, The Food and Drug Administration revealed that Emergent BioSolutions (NYSE: EBS) Baltimore plant, which manufactured Johnson and Johnson Covid-19 vaccines, was unsanitary and unsuitable to produce the...

Tag: Vaccine

Moderna Announces Development of Single-Dose Booster for Covid and Flu

“The Buzz” Show: Moderna, Inc. (NASDAQ: MRNA) Provisional Registration for Covid-19 Vaccine

Johnson & Johnson Reports Better-than-Expected Earnings

FDA to Place Warning on J&J Covid-19 Vaccine Regarding Rare Disorder

FDA adds Heart Inflammation Warning on Pfizer & Moderna Covid Vaccines

Moderna Applies for Full FDA Approval of its COVID-19 Vaccine

WHO Grants Emergency Use Authorization to Sinopharm Covid-19 Vaccine

CVS Health Tops Estimates & Boosts 2021 Guidance

“The Buzz” Show: INOVIO (NASDAQ: INO) Plans Phase 3 Trial for INO-4800

FDA Cites Drawbacks at Emergent BioSolutions Vaccine Plant

ABOUT US

Tweets